Peptide stacking - the practice of combining multiple peptides in a single protocol - is one of the more advanced topics in the biohacking community, and one of the most frequently misunderstood. Done correctly, stacking can produce synergistic effects that neither compound achieves alone. Done carelessly, it creates a confounding mess where you cannot attribute effects to specific compounds, cannot identify the source of adverse reactions, and may be paying for redundancy rather than synergy.

This guide covers the foundational principles that should govern any stacking decision, followed by the most evidence-informed combinations currently in use.

Why Stack at All?

The rationale for combining peptides falls into three categories:

Mechanistic Synergy

Two compounds operate via different mechanisms but produce complementary effects on the same outcome. The classic example: BPC-157 drives angiogenesis and growth factor upregulation; TB-500 promotes actin polymerization and cell migration. These are different phases of tissue repair. Neither alone addresses both.

Pathway Amplification

Two compounds operate on the same pathway but at different points in the signaling cascade, potentially amplifying the net effect. CJC-1295 (a GHRH analogue) and Ipamorelin (a ghrelin mimetic / GHRP) both stimulate growth hormone secretion, but through different receptor mechanisms. Their combination produces a greater GH pulse than either alone in clinical data - this is one of the few stacks with actual human research supporting the combination.

Complementary Goals

A protocol addressing multiple independent goals simultaneously - for example, using a healing peptide alongside a cognitive peptide. These are not synergistic in any mechanistic sense; they are simply parallel protocols running concurrently.

Foundational Rules Before You Stack

Run single compounds first. Before combining anything, establish your individual response to each peptide alone. This is the only way to understand what each is contributing and to identify your personal tolerance.
Change one variable at a time. If you add two compounds simultaneously and experience an unexpected effect, you have no way to attribute it. Introduce compounds sequentially with adequate washout or observation periods.
Document everything. Dates, doses, routes, timing, effects, side effects. Memory is unreliable. Logs are not.
Understand what you are taking. Do not add a compound to your protocol because someone on a forum said it stacks well. Understand the mechanism before combining.

Evidence-Informed Stacks

The Healing Stack: BPC-157 + TB-500

Compound	Typical Dose	Route	Frequency
BPC-157	250-500 mcg	SubQ (near injury site)	Daily
TB-500 (TB4 frag)	2-5 mg loading, 2 mg maintenance	SubQ	2x/week loading, 1x/week maintenance

Rationale: Mechanistic complementarity across different phases of soft tissue repair. BPC-157 supports angiogenesis and local growth factor response; TB-500 supports cell migration and actin cytoskeleton reorganization. Community evidence is extensive; no published combination data exists.

Cycle: 4-6 weeks. Run BPC-157 daily throughout; TB-500 typically 2x/week for 2 weeks loading, then 1x/week for maintenance.

The GH Optimization Stack: CJC-1295 + Ipamorelin

Compound	Typical Dose	Route	Timing
CJC-1295 (no DAC)	100-200 mcg	SubQ	Before sleep, on empty stomach
Ipamorelin	100-200 mcg	SubQ	Simultaneously with CJC-1295

Rationale: GHRH + GHRP dual stimulation of GH secretion. CJC-1295 (without DAC) is a GHRH analogue that acts on the GHRH receptor in the pituitary. Ipamorelin is a selective ghrelin mimetic that acts on the GHS-R1a receptor. Clinical data (published) supports greater GH release with the combination than either alone. This is the best-documented stack from a research standpoint.

Cycle: 8-12 weeks on, 4-8 weeks off. Longer cycles are common given the relatively benign mechanism.

Note: Avoid eating 90-120 minutes before and after injection - insulin blunts GH release significantly.

The Anti-Aging Skin Stack: GHK-Cu + Epithalon

Compound	Typical Use	Evidence Grade
GHK-Cu	Topical (serum) or SubQ	B (topical cosmetic data strong)
Epithalon	SubQ or intranasal	C (Russian literature, limited Western replication)

Rationale: GHK-Cu (copper tripeptide) has strong evidence for collagen synthesis stimulation, wound healing, and skin remodeling - particularly in topical form where cosmetic research is most robust. Epithalon is a tetrapeptide (Ala-Glu-Asp-Gly) studied primarily in Russian research for telomerase activation and longevity endpoints. The stack targets collagen quality and cellular aging via different mechanisms.

Caveat: Epithalon's evidence base is predominantly from Soviet-era and Russian-language literature. Western replication is limited. Approach with appropriate skepticism.

What NOT to Stack

Compounds with Receptor Overlap

Stacking two GHRPs (e.g., Ipamorelin + GHRP-6) produces diminishing returns and increased side effect exposure. Both compete for the same GHS-R1a receptor. Choose one based on your side effect tolerance (GHRP-6 increases cortisol and hunger significantly; Ipamorelin is more selective).

Multiple GHRH Analogues

Similarly, stacking CJC-1295 with Sermorelin or another GHRH analogue offers no mechanistic benefit - they bind the same receptor. Pick one.

Stacking Without Baseline Bloodwork

Any protocol affecting GH, IGF-1, or hormonal axes should be preceded by bloodwork establishing your baseline. This is not optional if you intend to understand what you are doing.

Monitoring and Biomarkers

For any peptide protocol beyond basic healing compounds:

GH-axis stacks: Fasting IGF-1 at baseline and 4-6 weeks into protocol
Any compound: Liver panel (AST/ALT) if running for more than 4 weeks
Hormonal compounds: Full hormone panel (testosterone, LH, FSH, cortisol) at baseline
Inflammation markers: hsCRP and ESR if running anti-inflammatory compounds like BPC-157

The Principle of Minimum Effective Dose

When stacking, the temptation is to add more compounds and increase doses. Resist this. The goal is to achieve your target outcome with the fewest compounds at the lowest effective dose. More compounds mean more variables, more cost, more potential for interaction, and less ability to attribute outcomes. Start minimally. Add only when you have exhausted the potential of what you already have.

How to Stack Peptides Safely: A Beginner's Guide